RhumbLine Advisers Portfolio holdings
AUM
$117B
This Quarter Return
+6.08%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$42.8B
AUM Growth
+$42.8B
(+8.5%)
Cap. Flow
+$1.5B
Cap. Flow
% of AUM
3.5%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
40
Increased
2,634
Reduced
168
Closed
44
Top Buys
| 1 |
Comcast
CMCSA
|
$151M |
| 2 |
Abbott
ABT
|
$22.4M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$19.7M |
| 4 |
Chevron
CVX
|
$19.6M |
| 5 |
Incyte
INCY
|
$18.6M |
Top Sells
| 1 |
SE
Spectra Energy Corp Wi
SE
|
$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
$30.3M |
| 4 |
Hilton Worldwide
HLT
|
$21.6M |
| 5 |
HAR
Harman International Industries
HAR
|
$13.8M |
Sector Composition
| 1 | Financials | 16.2% |
| 2 | Technology | 15.12% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.85% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TVIA
2801
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
| $70K | ﹤0.01% | 96,120 +3,683 | +4% | +$2.68K |
|
2802
Titan Pharmaceuticals
TTNP
$5.27M
| $69K | ﹤0.01% | 20,811 +5,932 | +40% | +$19.7K |
|
|
MN
2803
DELISTED
MANNING & NAPIER, INC.
MN
| $69K | ﹤0.01% | 12,108 +696 | +6% | +$3.97K |
|
2804
Valhi
VHI
$462M
| $68K | ﹤0.01% | 20,615 +1,176 | +6% | +$3.88K |
|
|
RELY
2805
DELISTED
Real Industry, Inc.
RELY
| $68K | ﹤0.01% | 23,832 -3,175 | -12% | -$9.06K |
|
2806
Aptevo Therapeutics
APVO
$5.39M
| $63K | ﹤0.01% | 30,502 +11,866 | +64% | +$24.5K |
|
|
FLNT
2807
Fluent
FLNT
$57.8M
| $63K | ﹤0.01% | 13,493 +715 | +6% | +$3.34K |
|
|
CVRS
2808
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $63K | ﹤0.01% | 48,260 +17,633 | +58% | +$23K |
|
2809
LifeVantage
LFVN
$165M
| $62K | ﹤0.01% | 11,551 -1,852 | -14% | -$9.94K |
|
2810
Salarius Pharmaceuticals
SLRX
$2.94M
| $62K | ﹤0.01% | +14,105 | New | +$62K |
|
2811
Rocket Pharmaceuticals
RCKT
$354M
| $60K | ﹤0.01% | 29,825 +12,001 | +67% | +$24.1K |
|
2812
Noodles & Co
NDLS
$33.1M
| $59K | ﹤0.01% | +10,186 | New | +$59K |
|
2813
Theriva Biologics
TOVX
$3.94M
| $59K | ﹤0.01% | 92,911 +32,764 | +54% | +$20.8K |
|
2814
CPI Card Group
PMTS
$177M
| $56K | ﹤0.01% | 13,419 +980 | +8% | +$4.09K |
|
2815
Tempest Therapeutics
TPST
$44M
| $56K | ﹤0.01% | 30,082 -4,802 | -14% | -$8.94K |
|
2816
Axsome Therapeutics
AXSM
$6.05B
| $53K | ﹤0.01% | +13,688 | New | +$53K |
|
|
NIHD
2817
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $53K | ﹤0.01% | 40,600 -12,307 | -23% | -$16.1K |
|
|
GNMX
2818
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $52K | ﹤0.01% | 28,185 +1,274 | +5% | +$2.35K |
|
2819
Lipocine
LPCN
$15.8M
| $51K | ﹤0.01% | 13,145 +624 | +5% | +$2.42K |
|
|
ABCD
2820
DELISTED
Cambium Learning Group, Inc.
ABCD
| $51K | ﹤0.01% | +10,310 | New | +$51K |
|
|
AST
2821
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| $51K | ﹤0.01% | 14,908 +858 | +6% | +$2.94K |
|
2822
ImmunityBio
IBRX
$2.21B
| $50K | ﹤0.01% | 14,143 -2,459 | -15% | -$8.69K |
|
2823
Altimmune
ALT
$338M
| $43K | ﹤0.01% | 53,135 +1,643 | +3% | +$1.33K |
|
2824
Cardiff Oncology
CRDF
$140M
| $43K | ﹤0.01% | 37,185 +12,270 | +49% | +$14.2K |
|
2825
Urban One Class D
UONEK
$35.8M
| $42K | ﹤0.01% | 12,754 +931 | +8% | +$3.07K |
|